PPI Drip Regimen for Bleeding Peptic Ulcers
Standard High-Dose Regimen
- The World Society of Emergency Surgery recommends administering an 80 mg intravenous bolus of a PPI followed by continuous infusion at 8 mg/hour for 72 hours for bleeding peptic ulcers after endoscopic hemostasis, with a total dose of 656 mg over 3 days, for patients with esomeprazole, pantoprazole, or omeprazole, considered a class effect 1, 2, 3
- This regimen applies to patients with high-risk lesions (Forrest 1a, 1b, 2a, or 2b) 4
Clinical Context and Timing
- The World Society of Emergency Surgery guidelines recommend starting PPI therapy as soon as possible, ideally before endoscopy, for patients with bleeding peptic ulcers 1, 2, 3
- The high-dose infusion protocol is specifically indicated after successful endoscopic hemostasis for high-risk lesions (Forrest 1a, 1b, 2a, or 2b) 1, 2
Evidence Supporting This Regimen
- A landmark RCT of 767 patients showed that 80 mg bolus plus 8 mg/hour infusion significantly reduced rebleeding (5.9% vs 10.3%, p=0.03) and need for repeat endoscopy compared to placebo, with a strength of evidence supporting the high-dose regimen 1, 3
- Meta-analyses confirm this regimen reduces rebleeding, need for surgery, and mortality, with moderate to high strength of evidence 1, 2
Administration Details
- The regimen consists of an initial bolus of 80 mg IV push, followed by continuous infusion of 8 mg/hour for 72 hours, with a preparation concentration to deliver 8 mg/hour 1, 2
After the 72-Hour Infusion
- The International Consensus Group recommends transitioning to oral PPI therapy after 72 hours, with oral PPI twice daily for patients at high risk for rebleeding on days 4-14, and once-daily oral PPI after day 14, for a total duration of 6-8 weeks following endoscopic treatment 5, 1, 2, 3
Important Caveats
- The primary treatment for active bleeding is endoscopic hemostasis, and PPI therapy is adjunctive, with the World Society of Emergency Surgery guidelines recommending not to use PPI infusion as a replacement for urgent endoscopy 1, 2
Esomeprazole Intravenous Administration Compatibility and Safety
Fluid Compatibility
- Normal saline (0.9 % NaCl) may be used as a diluent for single‑dose esomeprazole IV administration, but it is not the preferred solution for continuous infusion protocols that require sustained acid suppression. 6
IV Line Management
- To prevent precipitation, the infusion line should be flushed with 5 % dextrose before and after delivering the esomeprazole infusion, especially when other medications are administered through the same access. 6
- For an IV push (bolus) of esomeprazole, the drug can be delivered through a line containing either normal saline or 5 % dextrose, provided the line is appropriately flushed before and after the bolus. 6
Medication Mixing
- Esomeprazole must not be combined with other drugs in the same IV bag or syringe because compatibility data for multi‑drug admixtures are limited and precipitation risk is increased. 6